IFIC’s UCIE at the II Jornada Industria de la Ciencia – ICTS

On June 15th UCIE attended the II Jornada Industria de la Ciencia – ICTS Infraestructuras Científicas y Técnicas Singulares de física de partículas, fusión y astronomía – estrechando lazos con la industria, organized by CDTI, INNEUSTAR and INDUCIENCIA in Madrid.
The main objective of this conference is to serve as a meeting point to establish links between the Spanish science industry and the most relevant scientific infrastructures in the areas of particle physics, fusion and astronomy.
On the basis of the planned investment plans of this set of ICTS, the day discussed the most important technological challenges and opportunities for the science industry in the coming years, organized in a format of different round tables, which was quite participatory.
Finally, in the afternoon, B2B meetings were organized between companies, attendees and representatives of the infrastructures to promote mutual understanding and collaboration.
The ICTSs made available to the attendees the information on the challenges they plan to address in detailed summary sheets to facilitate the collection of information and participation. These sheets are available at the Unit and also on the event website.

All companies involved in the science industry attended and actively participated. UCIE innovation agents were able to explore opportunities for collaboration with companies and infrastructures.

Luis Caballero’s HYBRIMS project receives a special prize at the SECOT Awards for Excellence

The Spanish Seniors for Technical Cooperation (SECOT) association held the 15th edition of its SECOT Awards for Excellence, sponsored by the Repsol Foundation, on Wednesday 14 June at the CSIC Auditorium in Madrid.

In this edition, HYBRIMS (Hybrid Imaging Systems), a project promoted by IFIC (CSIC-UV) researcher Luis Caballero that develops medical devices for the accurate diagnosis of cancer, was awarded a runner-up distinction in the category of Highest Impact Project. The aim of this category is to recognise the project with the greatest impact on civil society in which the SECOT association has participated.

Jorge Cabero, Director of Innovation at the Fundación General CSIC, presented the award to Luis Caballero, accompanied by Adolfo Torres, Senior Advisor to the SECOT delegation in Madrid.

“I would like to thank once again the mentors of this project for their invaluable help, which, apart from supporting us and giving us strength on this hard road of entrepreneurship, has helped us to improve and focus on the central points of the business plan and product development. We hope to save many lives, which is what really matters to us,” said Caballero.

The event was attended by the vice-president of Scientific and Technical Research of the CSIC, José María Martell; the president of SECOT, Inocente Gómez Bordonado; and the director of Innovation and Entrepreneurship of the Repsol Foundation, Ane de Ariño Ochoa. Gonzalo Bans, well-known journalist, broadcaster and event presenter, acted as master of ceremonies.

On behalf of the president of the CSIC, Eloísa del Pino, Martell was in charge of opening the event and welcoming the attendees. In his speech, he stressed that “these awards represent an important milestone in SECOT’s commitment to support and promote entrepreneurship in our society”. In this sense, he stressed that these awards are also a stimulus to continue advancing and a support for the trajectory of these entrepreneurs, whose work “is fundamental for the economic and social development of our country”.

The SECOT Awards aim to recognise the effort and initiative of SECOT members in providing business advice to entrepreneurs, micro-enterprises and non-profit organisations.

About HYBRIMS

HYBRIMS aims at the development and viability of a Knowledge-Based Enterprise (KBE) created from the development of a patented medical technology that combines gamma and ultrasound imaging with real-time cancer biopsy guidance capabilities. This novel device adds the metabolic information provided by gamma imaging, which visualises the most active or aggressive areas of the tumour, to the morphological information obtained with ultrasound, allowing the specialist to obtain more precise information about the tumour.